Skip to main content
Caplight Logo









Acar'Up Consumer Health

Acar'Up Consumer Health

Private
BrusselsHealthcare & Life Scienceshttps://www.exaller.com/en/

Last Round

Early Funding

May 31, 2017

Est. Valuation

$4.01M

Total Funding Raised

$220,000

Company Overview

Acar'Up Consumer Health is a healthcare company that develops and markets ExAller, a clinically tested, plant-based solution designed to eliminate dust mites from homes to relieve allergy symptoms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Home & Lifestyle, Biotechnology

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

dust mite allergyallergy reliefanti-dust mite sprayallergy treatmentnon-toxic allergy solutionmite trapsnatural allergy remedyinsecticide-freeallergy preventionconsumer healthhome allergy reliefdust mite removalallergy managementhypoallergenic home

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acar'Up Consumer Health Comparables

Compare Acar'Up Consumer Health with similar companies based on industry and business-model similarity.

Acar'Up Consumer Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Ecology Works
78%
ICB Pharma sp. z o.o.
78%
Premo Natural Products
78%

Acar'Up Consumer Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 31, 2017
CrowdfundingJun 1, 2015
CrowdfundingApr 1, 2013

Key People

Founding team and executive leadership

Jonathan Feldbrugge

Chief Executive Officer

Executive Team

Acar'Up Consumer Health Investors

Notable investors and investment history

Acar'Up Consumer Health investors
InvestorRounds
The Innovation FundEarly Funding
InVenturesEarly Funding
TheodorusEarly Funding
SpredsCrowdfunding, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2017

    Closed a $4.01M round with participation from Theodorus and InVentures.

Acar'Up Consumer Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acar'Up Consumer Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acar'Up Consumer Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrussels
Employee Range5
Year Founded2014
Last FundingMay 31, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?